Two bleeding disorder treatments for both chronic and acute conditions, Qfitlia and Cablivi, have been approved in China.

Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseasesQfitlia, the first antithrombin-lowering therapy for hemophilia, ...

Investing.com -- Sanofi has received approval for two bleeding disorder treatments in China, expanding its hematology portfolio in the country. The French pharmaceutical company announced Thursday ...

A European medical regulator says it has found a possible link to the cause of the extremely rare blood clot disorder, tied to the Johnson and Johnson vaccine. It's the potential finding that medical ...

Sanofi (SNY) has received Chinese regulatory approval for two rare hematology drugs, Qfitlia and Cablivi, significantly ...

A team of researchers have made a new discovery in the field of hematology, providing an explanation for spontaneous and unusual blood-clotting that continues to occur despite treatment with full-dose ...

Could your heavy flow be cause for concern? Sherri Ozawa, MSN, RN, tells The Post that serious blood loss during menstruation could be a symptom of von Willebrand disease, a blood disorder that ...

Over the last year or so, three high-profile NBA superstars have received blood clot disorder diagnoses. In just the last two months, both Damian Lillard of the Milwaukee Bucks and the San Antonio ...

Cowboys Cheerleader Charly Barby Gives Health Update After Near-Death Experience From Blood Clot in Her Lung (Exclusive) originally appeared on Parade. Charly Barby is giving a health update after her ...